EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

The antimitotic agents combretastatin a 4 cs a4 and combretastatin a 2 cs a2 mechanism of binding to tubulin



The antimitotic agents combretastatin a 4 cs a4 and combretastatin a 2 cs a2 mechanism of binding to tubulin



Proceedings of the American Association for Cancer Research Annual Meeting 30: 565




(PDF emailed within 1 workday: $29.90)

Accession: 033718987

Download citation: RISBibTeXText



Related references

Antimitotic natural products combretastatin A-4 and combretastatin A-2: studies on the mechanism of their inhibition of the binding of colchicine to tubulin. Biochemistry 28(17): 6984-6991, 1989

Interactions of combretastatin, a new plant-derived antimitotic agent, with tubulin. Biochemical Pharmacology 32(24): 3864-3867, 1983

Development of a rapid and sensitive LC-MS/MS assay for the determination of combretastatin A4 phosphate, combretastatin A4 and combretastatin A4 glucuronide in beagle dog plasma and its application to a pharmacokinetic study. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 877(30): 3813-3821, 2009

Combretastatin dinitrogen-substituted stilbene analogues as tubulin-binding and vascular-disrupting agents. Journal of Natural Products 71(3): 313-320, 2008

Antineoplastic agents. 565. Synthesis of combretastatin D-2 phosphate and dihydro-combretastatin D-2. Journal of Natural Products 72(5): 876-883, 2010

Combretastatin A-4 analogues as antimitotic antitumor agents. Current Medicinal Chemistry 10(17): 1697-1722, 2003

Interactions with tubulin of natural and synthetic analogs of the antimitotic agent combretastatin a structure activity study. Federation Proceedings 46(4): 1322, 1987

Antineoplastic agents 429. Syntheses of the combretastatin A-1 and combretastatin B-1 prodrugs. Anti-Cancer Drug Design 15(3): 203-216, 2000

Interactions of tubulin with potent natural and synthetic analogs of the antimitotic agent combretastatin: a structure-activity study. Molecular Pharmacology 34(2): 200-208, 1988

Novel sulfonate analogues of combretastatin A-4: Potent antimitotic agents. Bioorganic & Medicinal Chemistry Letters 11(7): 871-874, 9 March, 2001

Sulfur containing double bond replacements of combretastatin A-4 as antimitotic agents. Abstracts of Papers American Chemical Society 221(1-2): MEDI 138, 2001

Recent advances in combretastatin based derivatives and prodrugs as antimitotic agents. Medchemcomm 8(8): 1592-1603, 2018

Antimitotic activity of structurally simplified biaryl analogs of the anticancer agents colchicine and combretastatin A4. Bioorganic & Medicinal Chemistry Letters 25(1): 117-121, 2015

Design and synthesis of cis-restricted benzimidazole and benzothiazole mimics of combretastatin A-4 as antimitotic agents with apoptosis inducing ability. Bioorganic & Medicinal Chemistry Letters 26(18): 4527-4535, 2016

Synthesis and evaluation of azetidinone analogues of combretastatin A-4 as tubulin targeting agents. Journal of Medicinal Chemistry 53(24): 8569-8584, 2011